#Homecare Self-Monitoring Device Share

[healthcarehubhh]

Homecare Self-Monitoring Devices: Empowering Patients to Take Charge of Their Health

Remote patient monitoring devices have seen a surge in popularity over the past few years. These innovative tools allow patients to monitor their vital signs and health metrics from the comfort of their own homes. Conditions that are commonly monitored remotely include chronic diseases like diabetes, heart disease, COPD and hypertension. Remote monitoring solutions offer convenience for patients and more efficient management of chronic conditions for healthcare providers. With remote monitoring, patients no longer need to regularly visit doctor's offices or clinics. Instead, they can track metrics like blood pressure, blood sugar, weight, pulse oximetry and more from home and automatically share the results with their care team via wireless transmission. This level of convenience has improved patient engagement with their health. It also frees up resources in the traditional healthcare setting. Wearable and Non-Invasive Monitoring Options A variety of remote patient monitoring devices are available for different health metrics. Popular wearable options include smartwatches equipped with sensors to track vitals passively throughout the day. Continuous glucose monitors have also revolutionized diabetes management. These small, waterproof sensors are worn on the body and can automatically transmit blood sugar readings to a companion smartphone app. Non-invasive devices are also prevalent. Examples include wireless blood pressure cuffs, scales, spirometers and pulse oximeters. Most connect to a smartphone or tablet via Bluetooth to record and transmit readings with just a few taps. This ease of use has made remote monitoring an appealing option even for older adults or those who lack comfort with technology. Audio instructions and visual guides help ensure proper use. Improving Chronic Disease Management For those managing chronic illnesses long-term, homecare self-monitoring device provides numerous benefits over traditional office visits alone. It allows for frequent symptom and metric tracking, sometimes continuously, between appointments. This level of visibility helps both patients and clinicians better recognize trends, catch issues early and fine tune treatment plans as needed. For example, continuous glucose monitors have helped increase time spent in target blood sugar range for many with diabetes. Remote monitoring also empowers patients to take a more proactive role in their care instead of simply reacting during office visits. Over time, this improved self-management can lead to better disease control and potentially reduced complications down the line. It also frees up clinic resources for those with more severe needs. Data Provides Insights for Care Teams The wealth of biometric and symptom data collected through remote monitoring gives care teams deeper insights into how conditions are truly progressing outside of brief appointments. Through automated reports and customizable alerts, clinicians now have more opportunities to intervene if a patient shows signs of a negative health trajectory. Remote monitoring also allows smaller practices and health systems to keep close tabs on large patient populations regardless of location. Real-time access to patient metrics streamlines chronic care coordination and facilitates quick response when action is needed. It flags issues that may have otherwise gone unrecognized until a serious event like a hospitalization occurred. Early detection through remote monitoring is transforming chronic disease management into a more proactive model focused on prevention over crisis intervention.

[globalinsightblog]

Disposable Blood Pressure Cuffs Market: $1.2B in 2023 to $2.1B by 2033, 5.7% CAGR

Disposable Blood Pressure Cuffs Market focuses on the production and distribution of single-use cuffs, essential for maintaining hygiene and infection control in healthcare settings. These cuffs are instrumental in reducing cross-contamination risks, particularly in hospitals and clinics. The market is driven by increasing healthcare awareness, stringent infection prevention protocols, and the rising incidence of chronic diseases that require frequent blood pressure monitoring. Innovations in this sector emphasize material sustainability and cost-effectiveness, aligning with the growing demand for eco-friendly medical disposables.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS25895 &utm_source=SnehaPatil&utm_medium=Article

In 2023, the market was estimated to have a volume of 320 million units, with projections to reach 500 million units by 2033. The adult segment dominates with a 45% share, followed by pediatric cuffs at 35%, and neonatal cuffs at 20%. The increasing preference for disposable cuffs is driven by the critical need for infection control measures in healthcare environments.

Single-patient use cuffs lead the market, given their significant role in preventing cross-contamination. Reusable cuffs follow closely, favored for their cost-effectiveness in non-critical care settings. The hospital segment dominates the end-user landscape due to the high volume of patient interactions and stringent infection control protocols. Ambulatory surgical centers and homecare settings also contribute to the market, reflecting a shift towards outpatient care and self-monitoring.

North America leads the market, propelled by advanced healthcare infrastructure and stringent regulatory standards. The United States is the top performer, benefiting from substantial healthcare expenditure and technological advancements. Europe ranks second, with Germany and the UK at the forefront due to strong healthcare systems and increasing adoption of disposable medical devices. The Asia-Pacific region is anticipated to exhibit substantial growth, driven by rising healthcare investments and heightened awareness about infection control.

Market Segmentation

Type: Reusable, Disposable

Product: Arm, Wrist, Thigh, Pediatric, Infant, Neonatal Cuffs

Technology: Automatic, Manual

Application: Hospitals, Clinics, Ambulatory Surgical Centers, Homecare

Material Type: Nylon, Polyester, Polyurethane

End User: Healthcare Providers, Home Users

Functionality: Single-Patient Use, Multi-Patient Use

Leading players like GE Healthcare, Hill-Rom Holdings, and SunTech Medical significantly shape the competitive landscape. The market’s growth is further supported by compliance with stringent regulatory standards such as ISO 13485 and FDA guidelines. Investments in R&D and product innovation are expected to enhance market growth, with a projected 10% increase in R&D expenditure by 2033. Emerging economies present significant opportunities due to rising healthcare infrastructure investments. However, challenges such as fluctuating raw material costs and the need for sustainable practices persist.

#DisposableBloodPressureCuffs #InfectionControl #PatientSafety #HealthcareInnovation #MedicalDisposables #EcoFriendlyHealthcare #SingleUseCuffs #BloodPressureMonitoring #GEHealthcare #HillRom #SunTechMedical #HealthcareTrends #ChronicDiseaseManagement #MinimallyInvasiveCare #MedicalDeviceMarke

[snehalblog]

Emerging Players and Innovations in the Global Blood Pressure Cuffs Market: A Comprehensive 2024 Market Forecast - UnivDatos

Key Highlights of the Report:

Ø Global burden of hypertension: Growing prevalence of hypertension is the major factor for increasing demand of blood pressure cuffs.

Ø Technological Advancement: Technological innovations such as automated blood pressure monitors are user-friendly, improve accuracy and provide quick responses. This quality of automated blood pressure monitors leads to growing popularity of this device among healthcare providers and patients.

Ø North America's Leadership: North America has exceptionally well-developed healthcare system, which benefitted the market players to bring innovative products to the healthcare providers as well as patients, which is driving growth of this region.

Ø Increase Adoption of Home Blood Pressure Monitors: Growing awareness regarding potential benefits of remote monitoring system is leading to increased adoption of home-based blood pressure monitors for continuous monitoring

Ø Asia-Pacific Growth: Market forces driving the market in the Asia-Pacific region due to government initiatives, policies and programs and growing interest of market players in investing in this region.

According to a new report by UnivDatos Market Insights, the Blood Pressure Cuffs Market was valued at USD 816.08 million in 2023 and is expected to grow at a CAGR of 5.34% during the forecast period (2024-2032). This is mainly due to the desire for rapid growth, more and more companies are participating in collaborative ventures such as mergers and acquisitions as ways to boost their capacities and shares and increase their knowledge of latest technological advancements. The increasing prevalence of hypertension is the major factor contributing to the growing demand for blood pressure cuffs. For instance, according to the World Health Organization (WHO) Global Report on Hypertension, around 1.3 billion adults in the year 2019, were affected by Hypertension. The report states that uncontrolled hypertension can lead to health complications such as stroke, kidney damage, heat attack and several other health problems. It further states that out of 1.3 billion people, only 21% of people got their hypertension controlled. Many companies are seeking major funding from venture capitalist firms to fuel research and development on effective blood pressure monitoring devices that is expected to further enhance blood pressure cuffs market.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=67421&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

Technological Advancement

With growing cases of hypertension and shortage of healthcare providers, technological advancements such as automated blood pressure monitoring devices saves a lot of time by giving fast and accurate responses. These are user friendly, reduces human errors and give healthcare providers the provision to monitor several patients in short duration of time. This quality of automated blood pressure monitors leads to growing popularity of this device among healthcare providers and patients. American Heart Association have also recommended use of automated BP machine with appropriate blood pressure cuffs size, to monitor blood pressure regularly at home for keeping track of their own health and encourage self-involvement in the disease management process. Additionally, digital technology advancements such as automated blood pressure monitors, are now widely used in homecare settings. Patients don’t require healthcare provider’s assistance to check their blood pressure and thus minimizes dependency. This gives the users a sense of self-awareness and responsibility towards their own health management and helps to track status of their own health by this continuous monitoring system. These frequent technological advancements are flourishing growth of blood pressure cuffs market.

Click here to view the Report Description & TOC: https://univdatos.com/get-a-free-sample-form-php/?product_id=67421&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

According to the report, the Asia-Pacific region is expected to be the fastest growing region in the forecast period

Asia-Pacific blood pressure cuffs market is the fastest growing region due to various factors such as increasing aging population, increased prevalence of cardiovascular diseases, growing investments within the region and increased awareness regarding potential benefits of remote monitoring. Additionally increased research and development activities and growing investments by key market players are also leading to the robust growth of this market within this region. Growing interest of leading players to invest in this emerging region is further flourishing growth of blood pressure cuffs market in Asia-Pacific. For instance, in June 2023, OMRON Healthcare Inc., which is a world leader in manufacturing blood pressure monitors, announced to establish a manufacturing plant in India to enhance production of blood pressure monitors within the country. This has planned due to increasing demand of blood pressure monitors in India. This investment is expected to bring innovation and development of blood pressure cuffs in Asia-Pacific region.

[priyablog26]

Healthcare Equipment Market May See a Big Move 2024-2030

 Healthcare Equipment  Market May See a Big Move 2024-2030

Global Healthcare Equipment   Market, Healthcare Equipment  Market Demand, Healthcare Equipment  Market Trends, Healthcare Equipment  Market Analysis, Healthcare Equipment  Market Growth, Healthcare Equipment  Market Share, Healthcare Equipment  Market Forecast, Healthcare Equipment  Market Challenges, Healthcare Equipment  Market Opportunity

At Intellect Markets, published a new research publication on "Healthcare Equipment  Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting Market associated stakeholders. The growth of the Healthcare Equipment  Market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @  https://intellectmarkets.com/report/healthcare-equipment-market/request-sample

Some of the key players profiled in the study are:

Diagnostic Imaging Equipment, Electrosurgical Equipment, Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, Endoscopic Devices, Laboratory Equipment, Others.

Scope of the Report of Healthcare Equipment  Market: Healthcare Equipment Market employs a robust research methodology, encompassing past, present, and future analyses. Analyse the drivers, restraints, opportunities, and challenges influencing the Healthcare Equipment market. The Global Healthcare Equipment Market report serves as a valuable resource for understanding the market dynamics and making strategic decisions in this evolving industry. The Global Healthcare Equipment Market report plays a crucial role in providing a comprehensive overview of the market dynamics. It evaluates key segments, identifies emerging trends, assesses drivers and restraints, and offers insights into the competitive landscape.

Market Trends: As the prevalence of chronic illnesses continues to escalate, healthcare organizations are increasingly prioritizing early detection and treatment. Concurrently, a growing number of patients undergo diagnostic and surgical procedures, propelling the expansion of the healthcare equipment market.

Opportunities: An integral facet of patient therapy in hospitals revolves around the utilization of equipment. The equipment deployed in hospitals significantly influences various activities and plays a pivotal role in determining the effectiveness of treatments. Additionally, it has a profound impact on patients' perceptions and the overall therapeutic experience. Healthcare equipment serves diverse purposes, including diagnosis, monitoring, and treatment. Advancements in medical technology facilitate accurate diagnosis across various medical indications, thereby enhancing treatment precision. The escalating prevalence of conditions such as arthritis, liver inflammation, cancer, renal diseases, diabetes, chronic pain, sciatica, and other nerve disorders is driving the heightened demand for healthcare equipment.

Market Drivers: The market is witnessing expansion due to the escalating trend of increased healthcare spending and the dynamically evolving healthcare landscape

There is a growing demand for portable devices as the focus shifts toward homecare settings.

Have Any Questions Regarding Global Healthcare Equipment  Market Report, Ask Our Experts@ https://intellectmarkets.com/report/healthcare-equipment-market/ask-an-expert

The Titled Segments and Sub-Section of The Market Are Illuminated Below: Healthcare Equipment Market Research Report – Segmented By Device Type (Diagnostic Imaging Equipment, Electrosurgical Equipment, Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, Endoscopic Devices, Laboratory Equipment, Others); End-User (Hospital, Diagnostic Imaging Centers, Dialysis Centers, Ambulatory Surgical Centers, Dental Clinics & Speciality Clinics, Other ).

Region Included are: Global, North America, Europe, Asia Pacific, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Türkiye, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Read Detailed Index of Full Research Study at https://intellectmarkets.com/report/healthcare-equipment-market

Thanks for reading this article; you can also get region wise report version like Global, North America, Middle East, Africa, Europe, South America, etc

Contact US: Intellect Markets, Unit No. 4, Lakshmi Enclave, Nizam pet, Hyderabad, Telangana, India - 500090 Phone: +1 347 514 7411, +91 8688234923 sales@intellectmarkets.com

[healthcaremarketfmi]

Telehealth and Telemedicine Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2033

We are excited to announce the groundbreaking advancements in Telehealth and Telemedicine, reshaping the landscape of healthcare delivery and empowering patients and providers alike. These transformative technologies leverage the power of digital communication and remote monitoring to expand access to healthcare services, improve patient outcomes, and enhance the overall efficiency of healthcare systems.

Telehealth and Telemedicine encompass a range of technologies and services that enable remote healthcare consultations, diagnosis, treatment, and monitoring. Through the use of secure video conferencing, mobile applications, remote monitoring devices, and electronic health records, patients can connect with healthcare professionals from the comfort of their homes or other remote locations. These technologies eliminate geographical barriers and enhance convenience, particularly for individuals with limited mobility, those in rural areas, or those in need of specialized care.

Experience Exponential Growth: Secure Your Sample Report and Dominate the Telehealth And Telemedicine Market! https://www.futuremarketinsights.com/reports/sample/rep-gb-14379

During the projected period, the global demand for Telehealth And Telemedicine Market is predicted to develop at a CAGR of 26.6 percent, reaching US$ 285.7 billion by 2027, up from an estimated US$ 87.8 billion in 2022.

The growing geriatric and medically underserved (especially rural) populations, the rising prevalence of chronic health conditions, the benefits of telemedicine considering the prevailing scarcity of healthcare professionals and care staff, and progressions in telecommunications, as well as rising user acceptance, are all driving growth in the telehealth and telemedicine market share.

In the aftermath of COVID-19 During the projected period, however, regional variances in rules, the likelihood of fraud, and the usage of social media for care provision will have a detrimental impact on market growth.

In recent years, telehealth technology has experienced enormous expansion. It not only allows patients to communicate with doctors over the internet, but it can also help to save healthcare costs. Because of these benefits, physicians and hospitals are eager to incorporate digital health technologies and telemedicine requirements into their practices. This has prompted the government to adopt telehealth-related rules and reimbursement standards.

Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14379

While lowering emergency room visits, hospitalization, primary care utilization, long-term care, home admissions, and patient travel costs, telehealth and telemedicine, particularly remote patient monitoring (RPM)/tele-homecare, can improve patient self-management, medication compliance, clinical outcomes, and patient & provider satisfaction. End-user demand for telehealth technology is being fueled by these benefits.

As per the recent telehealth and telemedicine market study, growth of the industry is hampered by a lack of infrastructure and technological barriers.

Adoption of the service may be hampered by technological and infrastructure hurdles in medium and low-income countries. For the integration and transmission of medical data, digital health methods involve the latest telecommunication gear, high-speed internet with high bandwidth, and storage capacity, which is still a challenge in many developing nations.

Furthermore, the high cost of installation and the scarcity of qualified healthcare professionals are two main challenges limiting the telehealth and telemedicine market share expansion.

As medical delivery adjusts to the widespread use of telehealth, there appears to be considerable potential in analytics, AI, and machine learning. As a result, data-driven analytics is a crucial part of assuring telehealth’s efficacy and efficiency and for the evolution of telehealth.

Telemedicine saves money for the users as compared to traditional approaches. The benefits of telemedicine include lowered healthcare costs while boosting efficiency, thanks to better chronic illness management, shorter travel times, pooled health professional staffing, and fewer and shorter hospital stays.

As a result of all of the identified components, the market is predicted to grow rapidly over the projected timeline.

[healthinfotech]

Glucose Monitoring Devices : Provides Real –Time Continuous Glucose Monitoring For People with Diabetes

The glucose monitoring devices market size is estimated to reach US$ 21,850.9 million by 2027 from US$ 12,628.3 million in 2018; it is expected to grow at a CAGR of 6.4% during 2019-2027.

Self-monitoring blood glucose (SMBG) is a modern diabetes management procedure, which involves the usage of blood glucose meters by patients to check their glucose levels quickly and provide an accurate measure of capillary glucose concentration. SMBG technology uses test strips, lancets, and blood glucose meters to achieve long-term glycemic control.

Diabetes is a disease that occurs when blood glucose, also called blood sugar, is too high. Blood glucose is the main source of energy and comes from the food we eat. Insulin, a hormone made by the pancreas, aids glucose from food getting into your cells to be used for energy. Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes diabetes type-I (also known as diabetes insipidus) and diabetes type-II (also termed as diabetes mellitus). Incidences and prevalence of diabetes are steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has grown alongside cultural and societal changes. In high-income countries, up to 91% of adults with the disease have type 2 diabetes. According to International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in 2017and it is expected to reach 629 million by 2045 across the globe.

Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Patients suffering from diabetes require frequent monitoring and external administration of insulin.

Obesity is one of the significant concerns globally. It is one of the major issues that affect people of all ages. According to World Health Organization (WHO), in 2016, more than 1.9 billion adults aged 18 years and older were overweight. Lack of exercise, unhealthy diet, and rapid growth in the obese population are expected to increase the susceptibility of diabetes among the population globally

The global glucose monitoring devices market, based on product, is segmented into glucometers, lancets, testing strips, and other glucose monitoring devices. The testing strips segment was the largest among the product subsegments in the market in 2018 and is expected to witness growth in its demand at the fastest CAGR of 7.0% during 2019–2027. The global glucose monitoring devices industry, based on end user, is segmented into home care and hospitals & clinics. The homecare segment held a larger share of the market in 2018 and is expected to witness growth in its demand at a faster CAGR during 2019–2027.

Some of the notable players in the global glucose monitoring devices market includes F. Hoffmann-La Roche Ltd., B. Braun Melsungen AG, Medtronic, Abbott, LifeScan, Inc., Ascensia Diabetes Care Holdings AG, Ypsomed AG, Omron Corporation, GE Healthcare and Nipro Corporation among others. The major market players within the recent years, have been observed to invest a substantial amount towards the development of new products. This implies a bright picture on the type of strategies majorly incorporated by the glucose monitoring devices market players to sustain their positions as well as to generate increased growth revenue in the glucose monitoring devices market. The global leaders in the market have been majorly adopting product launches and product up-gradation as one of the key strategy to improve its product lines in order to build up a customer centric benefits to its end users and enhance its geographic diversification.

[mrfrblogresearch02]

Point of Care Diagnostics/Testing Market Size  Analysis, Research Study 2027

Point of Care Diagnostics Market -Overview:

According to MRFR analysis, the global Point of Care Diagnostics Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The medical equipment utilized to get an immediate result in examining various diseases, diabetes, cancer, heart diseases, are defined as point of care (POC) diagnostics. These devices include glucose monitoring kits, infectious disease testing kits, pregnancy and fertility testing kits, and drug abuse testing kits, to name a few.

The tests can be employed in a variety of circumstances, with each requiring a different course of action depending on the outcome. The drug screening kit can be used for several different purposes. In general, the test is used to determine whether or not a person has consumed any narcotic substance. Sportsmen and women can take the test to ensure that no narcotic substances are present before competing. The advent of portable POC devices supporting government policies is supplementing the POC diagnostics/testing market, with an increasing number of chronic conditions such as diabetes around the globe and a relatively small number of healthcare facilities in developing nations. In addition, market participants are introducing digital and wireless POC solutions to improve diagnosis efficiency and accuracy.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: The market for point-of-care diagnostics is dominated by North America (which includes the United States and Canada). With the rising incidence and prevalence of lifestyle diseases, North America is gaining traction. More awareness of self-testing and home care goods and a considerable adoption of novel technologies are projected to play a crucial role in driving the point-of-care diagnostics market in North America. Healthcare product providers are merging and acquiring current market participants to extend their product availability across the region. Lacuna Diagnostics (US), a company that provides digital cytology point of care and telehealth services, was bought by Heska Corporation (US).

Owing to the limited availability of healthcare workers, various manufacturing facilities, changing demographics, and increasing consumer healthcare expectations, the Asia-Pacific point of care diagnostics/testing market is expected to be the fastest-growing market sector. Furthermore, comforting government rules, significant funding by industry participants, and innovative technically advanced solutions are all elements boosting the point of care diagnostics/testing market.

Segmentation: The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[itssashasharma]

Global Patient Monitoring Devices Market worth $ 55.1 billion by 2025 : Availability of wireless monitoring devices

Integration of monitoring technologies in smartphones and wireless devices is a key trend in patient care, resulting in the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, ambulatory wireless EEG recorders, and ambulatory event monitors are the key factors supporting the growth of the market.

According to the new market research report “Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) – Global Forecast to 2025″, published by MarketsandMarkets™, the Patient Monitoring Devices Market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Browse in-depth TOC on “Patient Monitoring Devices Market” 328 – Tables 39 – Figures 354 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678 The growth of this market is mainly driven by the growing number of hospitals across major markets, increasing awareness about vital parameter monitoring for treatment and diagnosis of chronic diseases coupled with the increasing adoption of wearable and wireless patient monitoring devices for homecare. Moreover, rising R&D investments by the key players operating in the market to develop advanced monitoring devices coupled with growing funding & grants for commercialization and development of monitoring devices are other important factors to drive the market growth in the near future. As a result of the pandemic, during March 2020 and throughout the second quarter of 2020, access to customers to sell and implement the patient monitoring devices (such as neuromonitoring devices, weight monitoring devices) diminished as hospitals became primarily focused on the COVID-19 pandemic. The pandemic has led to a significant increase in the demand for remote monitoring and patient engagement solutions. COVID-19 has led to a significant surge in demand for patient monitoring systems, and manufacturers are increasingly focusing on expanding production to meet the increasing need for respiratory monitoring devices, multi-parameter monitoring devices, blood glucose monitoring devices, cardiac monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, and fetal/neonatal monitoring devices. The ECG devices sub segment of cardiac monitoring devices products to hold major market share by 2025 Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices. The cardiac monitoring devices products segment is further divided into ECG devices, event monitors, implantable loop recorders (ILRs), mobile cardiac telemetry (MCT) monitors, and smart/wearable ECG monitors. Among the cardiac monitoring devices products, the ECG devices segment held a major share of the market in 2019. The wide applications of ECG devices in CVD management are a major factor contributing to the growth of this market segment. Other factors supporting market growth include the low cost of ECG devices and the simplicity, easy-to-access nature, and compact & ergonomic design of these devices. Based on product, the blood glucose monitoring systems segment is expected to account for the largest share of the patient monitoring devices market in 2019 Based on type, the blood glucose monitoring systems market has been segmented into the self-monitoring blood glucose systems and continuous glucose monitoring system. Among these, the self-monitoring blood glucose systems sub-segment dominated the market in 2019. The major share of the segment is attributed to the rising adoption of integrated blood glucose monitoring systems in developing as well as developed countries. New products have been introduced in the market that allow for easier result interpretation. LifeScan, for example, launched the OneTouch Verio Flex in 2016, which comes with the ColorSure technology to determine if blood glucose levels are low or high. Many

manufacturers offer smartphone-connected meters that allow information transfer using Bluetooth. Request for sample pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=678 North America is expected to dominate the global patient monitoring market in 2019 North America, comprising the US and Canada, accounted for the largest share of the patient monitoring devices market in 2019. Increasing number of clinical trials validating patient monitoring devices and a growing number of approvals for patient monitoring. Are the major factors driving market growth in North America. Customers in North America are moving towards homecare patient monitoring, which requires non-invasive patient monitoring devices. This trend will have a positive impact on the market. Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (US), among othersare some of the major players operating in the global patient monitoring devices market. Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting Browse Related Reports: Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End-User (Hospital, Home Care), Indication – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/patient-healthcare-monitoring-systems-devices-market.asp Visit Our Web

Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/patient-monitoring-devices.asp

[bhandvalkar94]

Blood Glucose Meter Market - Growth Factors, Recent Trends, COVID-19 Impact, and Forecasts (2021 - 2030)

The research report titled Blood Glucose Meter market has recently been added by Absolute Markets Insights to its massive database which offers a lucid understanding of various business aspects of the Blood Glucose Meter market. The market report has been studied by means of primary and secondary research techniques. The report also covers the extensive data of historical records, existing scenarios, and future market growth prospects. Additionally, the report also offers SWOT analysis to discover market propellers and restraints of the businesses. The report also offers a holistic snapshot of the competitive landscape which helps to differentiate the competition at global and national level. In order to discover the risks and challenges faced by businesses, several types of business model have been examined.

Graphical presentation techniques such as info graphics, chart, tables, and pictures are touched upon while curating this report. This helps to generate a strong footing for detailed analysis of recent trends and technological advancements in the Blood Glucose Meter market. Furthermore, the case study provides region wise productivity in a concise manner. The report also offers facts of market shares which has been held by several Blood Glucose Meter market industries. Different effective market channels and business strategies have been explained in detail in the report to formulate the best strategies to the readers.

Browse the Full Information of this report: https://www.absolutemarketsinsights.com/reports/Blood-Glucose-Meter-Market-2019-2027-707

Top Key Players includes in this report: Abbott, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Dexcom, Inc., DiaMonTech AG, Dottli, Dr Trust., Dr.Morepen, Gluco-wise, Health2Sync, Informed Data Systems Inc. and One Drop, Integrity Applications, La société PKvitality, LifeScan IP Holdings, LLC, Medtronic, Medtronic Pvt. Ltd, Roche Diabetes Care, Sanofi-Deutschland GmbH, Senseonics, Incorporated, SOCIALDIABETES, S.L. and Terumo Europe NV amongst others.

Key Findings of the Report:

The global blood glucose meter market was valued at US$ 10726.36 Mn in 2020 and is anticipated to witness a compound annual growth rate of 7.11% over the forecast period due to the growing number of diabetes patients.

Based on the type, wearable glucose monitoring devices are anticipated to witness high growth in global blood glucose meter market over forecast years. The continuous glucose monitoring capabilities of these devices provide regular updates to the user and prevents adverse outcomes resulting from steep fall or rise in blood sugar levels.

The need for regular monitoring of blood glucose for determining the dosage of insulin and tracking fluctuations in sugar levels is driving the share of self-usage/homecare application across global blood glucose meter

North America accounted for the highest market share in global blood glucose meter market in 2018. Asia Pacific is expected to register the highest compound annual growth rate over the period of next eight years. The rising awareness about diabetes management amidst various government programs, is anticipated to drive the growth.

Global Blood Glucose Meter Market:

By Product

Self-Monitoring Blood Glucose (SMBG) Systems

Continuous Glucose Monitoring Devices

Digital Solutions

By Type

Wearable

Handheld

By Sales Channel

Online

Offline

By Application

Hospitals

Clinical Laboratories

Physicians

Self-Usage/Homecare

Diagnostics Centers

Others

By Region

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Contact Us:

Company: Absolute Markets Insights Email id: sales@absolutemarketsinsights.com Phone: +91-740-024-2424 Contact Name: Shreyas Tanna Website: https://www.absolutemarketsinsights.com/

[gmiresearch]

Diabetes Care Devices Market Research Report

Global Diabetes Care Devices Market

The GMI Research forecasts that the Diabetes Care Devices Market is witnessing an upsurge in demand over the forecast period. This is mainly due to the mounting cases of diabetes owing to the accelerating geriatric population.

Request for a FREE Sample Report on Diabetes Care Devices Market

Introduction of the Diabetes Care Devices Market

Diabetes care devices are used to monitor the glucose level in the diabetic patient's body and facilitate insulin delivery into the patient's body. There are mainly two types of diabetes care devices, including the blood glucose monitoring device and the insulin delivery device. The regular monitoring of diabetes improves outcomes and helps in adjusting treatment in real-time. These devices are often used in hospitals, clinics, and other surgical centers.

Key Players of the Global Diabetes Care Devices Market:

·         Abbott Laboratories

·         Bayer Healthcare

·         Becton Dickinson and Company

·         Roche Holding AG

·         Biotronik SE

·         Medtronic plc

·         GlaxoSmithKline

Diabetes Care Devices Market Dynamics (including market size, share, trends, forecast, growth, forecast, and industry analysis)

Several factors responsible for the growth of the global Diabetes Care Devices Market are increasing technological modernizations, accelerating disposable income of middle-class families, and the mounting urban population. In addition, the rising cases of diabetes and obesity led by the fuelling consumption of junk food and alcohol will further strengthen the Diabetes Care Devices market size. In accordance with the World Health Organization, the cases of diabetes touched 8.5% in 2014, especially in the middle to low-income economies. Approximately 1.6 million deaths in 2015 were directly related to diabetes, with half of the patients below the age of 70 years. The manufacturers are increasingly emphasizing technological enhancement in the product to deliver more accurate results. Thus, this continuous product innovation will bring enormous growth opportunities for the market. In addition, the intensified disbursement in the healthcare sector and the surging adoption of these devices for self-monitoring and tracking of diabetes are supplementing the market growth. However, the rising consciousness about the side effects of these devices will hamper the Diabetes Care Devices industry growth.

Product Type Segment Drivers

Based on the product type, blood glucose monitoring will dominate the market due to the transformation and technological advancements in these devices. The device offers a more accurate measurement of the glucose level and warns if the glucose level goes too low or too high. On the other hand, insulin delivery is contemplated to witness faster growth in the market over the forecast period. This is primarily due to adopting these devices across healthcare professionals and patients led by their remarkable advantages like higher stability and better properties.

End-User Segment Drivers

Based on the end-user, home care settings are expected to experience a robust demand in the next few years due to their user-friendly feature at an economical price range. The inclination of end-users to use these devices at home rather than going to clinics or healthcare centers for regular health check-ups with the increasing research and development activities to make the devices more convenient has propelled the Diabetes Care Devices market growth.

Regional Drivers

Based on the regional coverage, Asia Pacific is projected to lead the market owing to the aggravating allowances by government and private towards healthcare infrastructure and the substantial growth in population rate in the developing economies, including India, China, and Japan. In addition, the mounting consumer awareness regarding their benefits coupled with the development in technologies and the initiatives taken by the government to spread awareness will bolster the Diabetes Care Devices market share.

Diabetes Care Devices Market Segmentation:

Segmentation by Product Type

·         Blood Glucose Monitoring Device

·         Insulin Delivery Device

Segmentation by End-User

·         Hospitals

·         Homecare Setting

·         Others

Segmentation by Region:

·         North America

o   United States of America

o   Canada

·         Asia Pacific

o   China

o   Japan

o   India

o   Rest of APAC

·         Europe

o   United Kingdom

o   Germany

o   France

o   Spain

o   Rest of Europe

·         RoW

o   Brazil

o   South Africa

o   Saudi Arabia

o   UAE

o   Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting company that offers business sights and market research reports for every enterprise, including small & medium enterprises and large organizations. Our research team helps the clients to understand the impact of market dynamics such as market size, share, drivers, growth opportunities, and other aspects. We have a team of analysts and industry experts who conduct market intelligence studies to ensure relevant and fact-based research across a wide range of sectors such as FMCG, Technology, Energy, Healthcare, and other industries. We collect relevant information about the industry using both internal and external databases. Our main focus is to keep our clients abridged of the emerging opportunities and challenges in a wide range of industries. We provide step-by-step assistance to our client through strategic and consulting services to reach a managerial and actionable decision. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping businesses stay ahead of the curve.

Media Contact Company Name: GMI RESEARCH Contact Person: Sarah Nash Email: enquiry@gmiresearch.com Phone: Europe – +353 1 442 8820; US – +1 860 881 2270 Address: Dublin, Ireland Website: www.gmiresearch.com

[esglatestmarketnews]

Glucose Biosensor Market Challenges, Strategies And Forecast till 2022

June 23, 2021: The global glucose biosensor market was estimated at USD 15.3 billion in 2015 and is anticipated to reach USD 31.0 billion by 2022. Biosensors are identified as analytical equipment that change a biological reaction into electrical indicator and help in measuring an extensive range of analytic comprising gasses, bacteria, organic compounds and others. It includes the biological component that works as a sensor & an electrical constituent and utilized to distinguish and pass on the signal. Glucose biosensors are usually utilized to sense concentration of sugar/glucose in patients. Bio-constituents such as proteins comprising nucleic acids, enzymes, and others are utilized as biosensors in lieu to examine the concentration of glucose in a patient.

Some key factors accredited to the expansion of this market comprises the growing occurrence of diabetes around the globe, the growth of the technically advanced product, increasing the requirement for non-invasive products and minimally sized products, increasing patient consciousness levels, and the requirement for early diabetes recognition. However, the existence of other options for supervision of diabetes, for instance, laboratory process is expected to confine market expansion over the forecast period. Rising occurrence of diabetes worldwide is the main factor contributing towards the expansion of this industry. Glucose monitoring of blood is utilized as an essential instrument in diabetes management.

As upholding of normal blood glucose levels is significantly important for the patients going through diabetes, a progression of appropriate glucose biosensor has been made to congregate the demands of the patients afflicted with this extremely rampant disorder. Moreover, the increasing requirement for self-monitoring equipment has amplified the utilization of biosensors particularly in handy forms. These sensors are currently available as miniature and minimally invasive equipment that calculate glucose levels in a patient. Scrutinization of glucose level in blood at regular period is very important key factor demanded disease management. Due to this fact, a number of technical advancements are being conceded out in the production of sensors. Moreover, production of dependable and precise glucose biosensors is expected to pose the challenge for market players.

Request a Free Sample Copy of this Report @ https://www.millioninsights.com/industry-reports/glucose-biosensor-market/request-sample

The initiation of technical advancements is likely to play an essential role in enhancing usage rates. This is obvious from the improvement of non-invasive and minimal glucose biosensor in this industry. Glucose biosensors industry is expected to observe soaring growth owing to escalating diabetic patient population worldwide. Thus, escalating occurrence of diabetes will augment the requirement for glucose biosensor and hence propels the industry growth. In totaling, growing requirement for point of care diagnostics and home care diagnostics, and increase in utilization of glucose biosensor in nonmedical functionality will further encourage the industry of glucose biosensor. Moreover, soaring cost for the cure by biosensor is expected to restrain the industry growth of glucose biosensors over the forecast period.

On the basis of types, there are typically two types of glucose biosensors purposely amperometric biosensors and fluorescence glucose. Among these two kinds, amperometric glucose biosensor is extensively accessible commercially. Amperometric biosensor operates by the way of glucose oxidase. Amperometric biosensor oxidizes glucose directing to the creation of hydrogen peroxide, which is noticed by the electrode and the level of glucose is examined. Moreover, by the improvement in fluorescent glucose biosensor, it is likely to capture the huge market share over the forecast period. This biosensor works on fluorescence process that calculates the level of blood glucose with additional precision.

The operational life of probe of this biosensors is of better quality in comparison to amperometric biosensors which is expected to fuel the market for this segment biosensors. On the basis of end-use, the market can be segregated into home care diagnostics, hospitals, and others. The home care diagnostics is expected to grow rapidly over the forecast period owing to increasing demand coupled with latest innovation & advancement that are been inculcated into these devices to make it more précised and accurate. Hospital sector is expected to capture maximum share over the forecast period. On the basis of a geographical region, the market can be segregated into North America, Europe, Asia Pacific and Rest of World. North America is expected to capture maximum revenue over the forecast period owing to increasing cases of diabetes in North America coupled with technological advancement that is happening in this area. Europe is expected to capture second largest revenue over the forecast period. Asia Pacific is expected to grow rapidly over the forecast period owing to increasing aging population coupled with increasing consumer awareness about these devices.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/glucose-biosensor-market

Some of the key players in the market are as follows Roche, Abbott, Siemens Healthcare Diagnostics, Nova Biomedical Corp, Animas Corporation, M-Biotech, LifeScan, AgaMatrix, Medtronic Diabetes and others. In present years, carbon nanotubes have got extensive attention as capable carbon-based nanoelectronic equipment owing to their exceptional chemical, physical and electrical properties, specifically a soaring surface-to-volume proportion, their superior electron transfer properties, and their soaring thermal conductivity, carbon nanotubes are being utilized efficiently as electrochemical sensors. The incorporation of carbon nanotubes as a functional group offers a solid and good support for the control of enzymes and their integration with glucose biosensors offers a quick detection rate and high accuracy. A number of R&D initiatives are being taken by active players in the market to capture maximum revenue and thus offer that devices which are highly précised.

Market Segment:

Glucose Biosensors End-use Outlook (Revenue, USD Million, 2012 - 2022)

• Hospitals

• Homecare Diagnostics

• Others

Biosensors Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• Asia Pacific

• China

• India

• Latin America

• Brazil

• Mexico

• MEA

• South Africa

• Saudi Arabia

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

[waaaiz]

Diabetes Care Devices Market Research Report

The GMI Research's latest analysis reveals that the Diabetes Care Devices Market is slated to register a CAGR of 5.6% over the forecast period. This is mainly attributed to the growing technological advancements and expenditure on the healthcare industry, followed by the rising cases of diabetes and obesity.

Request for a FREE Sample Report on Diabetes Care Devices Market

Diabetes Care Devices Market’s leading Manufacturers:

·        Abbott Laboratories

·        Becton Dickinson and Company

·        Bayer Healthcare

·        Roche Holding AG

·        Medtronic plc

·        Dexcom Inc

·        Biotronik SE

·        GlaxoSmithKline

Diabetes Care Devices Market Dynamics (including market size, share, trends, growth, forecast, and industry analysis)

Key Drivers

The growing technological advancements and expenditure on the healthcare industry, followed by the rising cases of diabetes and obesity, are the key drivers contributing to the growth of the diabetes care market size. As per the WHO, the prevalence rate of diabetes disease about 8.5% in 2014 globally. There is a strong prevalence rate for diabetes in the middle-to low-income economies. In 2015, approximately 1.6 million deaths were regarding diabetes, and around half of the patients were below the age group of 70 years. The rising consumption of junk food and alcohol intake is boosting the growth of diabetes care devices share in terms of revenue worldwide. The diabetes care device manufacturers majorly emphasize technological development in the product to deliver more correct results. Rapid product innovation will bring lucrative opportunities for the market, thus attracting many consumers to opt for advanced devices. Additionally, the rising disposable income of middle-class families and increasing urbanization are promoting the consumers to adopt diabetes care devices for tracking diabetes and regular self-monitoring. On the other edge, the growing consumer awareness associated with the side effects regarding some of the diabetes care devices will hinder the growth of the market over the coming years.

Product Type Segment Drivers

Based on the product type, the blood glucose monitoring devices are projected to dominate the market over the coming years due to the growing modification and technological development in diabetes care devices. It also offers an exact measurement of the glucose level and provides a warning if the glucose level goes too high or low. On the other hand, the insulin delivery devices are anticipated to rise at a higher CAGR over the coming years. This is mainly due to the strong adoption of these devices among healthcare professionals and patients as a result of their exceptional benefits like technologically advanced properties and high stability.

Regional Drivers

Based on the region, the Asia Pacific is expected to dominate the market over the coming years due to the growing government and private funding towards healthcare infrastructure. The increasing population rate in emerging countries, such as Japan, China, and India, and the rising consumer awareness associated with the benefits provided by these devices will further promote the consumers towards the use of diabetes care devices. The rapid advancement in technologies and the various initiatives taken by the government to spread awareness will further support the markets' demand.

Diabetes Care Devices Market Segmentation:

Segmentation by Product Type:

·        Blood Glucose Monitoring Device

·        Insulin Delivery Device  

Segmentation by End-User:

·        Hospitals

·        Homecare Setting

·        Others

Segmentation by Region:

·        North America

o   United States of America

o   Canada

·        Asia Pacific

o   China

o   Japan

o   India

o   Rest of APAC

·        Europe

o   United Kingdom

o   Germany

o   France

o   Spain

o   Rest of Europe

·        RoW

o   Brazil

o   South Africa

o   Saudi Arabia

o   UAE

o   Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is one of the leading market research and consulting company that offers consulting services, syndicated research reports, and customized market research reports. We help our client to make informed business decisions and provide market intelligence studies related to the various industries such as automotive, energy, healthcare, chemicals, technology, and other sectors. Our research teams include seasoned analysts and researchers have hands-on experience in every regions, including Asia-pacific, Europe, North America, and the Rest of the World. Our market research report provides in-depth analysis, which contains refined forecasts, a bird's eye view of the competitive landscape, factors impacting the market growth, and several other market insights to aid companies in making strategic decisions. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to help our clients to stay ahead of the curve.

Media Contact Company Name: GMI RESEARCH Contact Person: Sarah Nash Email: enquiry@gmiresearch.com Phone: Europe – +353 1 442 8820; US – +1 860 881 2270 Address: Dublin, Ireland Website: www.gmiresearch.com

[priyacmi]

Self-care Medical Devices Market

Self-care medical devices are used for measuring and monitoring various vital parameters of a patient. These devices play an important role in monitoring blood sugar level, heart rate, hypertension and other conditions.

Blood glucose monitors, blood pressure monitors, temperature monitors, Holter monitors, pregnancy/fertility test kits, sleep apnea monitors, nebulizers, and pedometers are some of the most commonly used self-care medical devices.

The global self-care medical devices market is estimated to account for US$ 18,090.1 Mn in terms of value and is expected to reach US$ 30,419.8 Mn by the end of 2027.

Global Self-care Medical Devices Market: Drivers

Increasing prevalence of lifestyle diseases is expected to propel growth of the global self-care medical devices market over the forecast period. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

Approval and launch of new devices is expected to propel growth of the global self-care medical devices market over the forecast period. For instance, in April 2020, Axonics Modulation Technologies, Inc. received the U.S. Food & Drug Administration approval for its next generation rechargeable implantable neurostimulator, r-SNM System, under a premarket approval supplement.

Blood Glucose Monitors held dominant position in the global self-care medical devices market in 2019, accounting for 57.8% share in terms of value, followed by blood pressure monitors and sleep apnea monitors, respectively.

Figure 1. Global Self-care Medical Devices Market Share (%), by Value, by Product Type, 2019

Global Self-care Medical Devices Market: Restraints                          

Product recalls are expected to hinder growth of the market. For instance, in September 2019, Johnson and Johnson Vision Care recalled two full and one partial master lots of 1-DAY ACUVUE MOIST for ASTIGMATISM Contact Lenses in EMEA, owing to failure to meet quality standards.

Moreover, inaccuracy of self-care medical devices is also expected to limit growth of the market. Self-care devices such as pregnancy kits and fertility test kits provide false positive results.    

Report Coverage

Details

Base Year:

2019

Market Size in  2019:

US$ 16,853.7 Mn

Historical Data for:

2016 to 2019

Forecast Period:

2020 to 2027

Forecast Period 2020 to 2027 CAGR:

7.7%

2027 Value  Projection:

US$ 30,419.8 Mn

Geographies covered:

  North America: U.S., Canada

  Latin America: Brazil, Argentina,       Mexico, Rest of Latin America

  Europe: Germany, U.K.,       Spain, France, Italy, Russia, Rest of Europe

  Asia Pacific: China, India, Japan,       Australia, South Korea, ASEAN, Rest of Asia Pacific

  Middle East: GCC Countries,       Israel, Rest of Middle East

  Africa: South Africa, North       Africa, Central Africa

 Segments covered:

  By Product Type: Blood Glucose       Monitors, Blood Pressure Monitors, Temperature Monitors, Holter       Monitors, Pregnancy/Fertility Test Kits, Sleep Apnea Monitors,       Nebulizers, Pedometers.

 Companies covered:

3M Healthcare, Abbott Laboratories, Bayer AG, GE  Healthcare, F .Hoffmann-La Roche, Johnson & Johnson, Medtronic, Inc.,  Omron Healthcare, Philips Healthcare, and ResMed, Inc.

Growth Drivers:

  Product Launches

  Increasing demand for homecare treatment

 Restraints & Challenges:

  Alternative treatment options

  High costs

 Side effects and risks associated with implantation of self-care medical devices is expected to hinder growth of the market. Neuromodulation implanting surgery has certain side effects on the body such as allergy and hoarseness. The neuromodulation devices also carry some risks, owing to the electrical impulses generated by it. The device may cause damages to the nearby nerves and blood vessels, as in the case of a VNS pacemaker, it might cause damages to the vagus nerve, carotid artery and jugular veins.

Self-care Medical Devices Market Report Coverage

Global Self-care Medical Devices Market: Opportunities 

High prevalence of cardiovascular diseases in emerging economies is expected to offer lucrative growth opportunities for players in the global self-care medical devices market. For instance, the Journal of American Collage of Cardiology reported a prevalence of 54.6 million for cardiovascular diseases in India in a study published in July 2018.       

Moreover, digitalization in self-care medical devices is also expected to aid in growth of the market. For instance, in June 2020, AireHealth, a developer of portable nebulizer that pairs with a smartphone app for remote monitoring, acquired BreathResearch, a respiratory health company, in order to develop its digital respiratory health platform.

Increasing healthcare expenditure is expected to offer lucrative growth opportunities for players in the global self-care medical devices market. For instance, according to The Centers for Medicare & Medicaid Services, the U.S. health spending is projected to reach nearly US$ 6.0 trillion by 2027.

The global self-care medical devices market was valued at US$ 16,853.7 Mn in 2019 and is forecast to reach a value of US$ 30,419.8 Mn by 2027 at a CAGR of 7.7% between 2020 and 2027.

Market Trends/Key Takeaways

Major players in the market are focused on offering guidelines regarding use of self-care devices during Covid-19 pandemic. For instance, in April 2020, Abbott Laboratories announced that the FreeStyle Libre 14 day system, a CGM technology, can be used in the hospital setting 2 during the COVID-19 pandemic, according to the U.S. Food and Drug Administration (FDA).

Self-care devices are effective in management of various chronic disorders. For instance, in June 2020, Abbott Laboratories announced new late-breaking data that demonstrated efficacy of its FreeStyle Libre system, in reducing hemoglobin A1c (HbA1c) levels for people living with type 2 diabetes.

Self-care medical devices are currently regulated by Council Directive 93/42/EEC concerning medical devices. However, in May 2020, this Directive will be replaced by Regulation (EU) 2017/745 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC.

The market has witnessed increasing adoption of smartphone-based pedometers, due to increasing use of smartphones. For instance, according to Pew Research Center, as of February 2019, 81% of U.S. adults used smartphones compared to 77% in October 2018. 

   https://www.coherentmarketinsights.com/insight/request-sample/3957

https://www.coherentmarketinsights.com/insight/request-pdf/3957

Global Self-care Medical Devices Market: Competitive Landscape

Major players operating in the global Self-care Medical Devices Market include, 3M Healthcare, Abbott Laboratories, Bayer AG, GE Healthcare, F .Hoffmann-La Roche, Johnson & Johnson, Medtronic, Inc., Omron Healthcare, Philips Healthcare, and ResMed, Inc.

Global Self-care Medical Devices Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in January 2020, ResMed Inc. launched AirFit F30i, its first tube-up full face CPAP mask.

October 2019: OMRON Healthcare, Inc. launched newly redesigned models of its blood pressure monitors with new features

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

·         Customized Market Research Services

·         Industry Analysis Services

·         Business Consulting Services

·         Market Intelligence Services

·         Long term Engagement Model

·         Country Specific Analysis

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

  Source https://www.coherentmarketinsights.com/market-insight/self-care-medical-devices-market-3957

[itssashasharma]

Patient Monitoring Devices Market worth $ 55.1 billion by 2025 : Availability of wireless monitoring devices

Integration of monitoring technologies in smartphones and wireless devices is a key trend in patient care, resulting in the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, ambulatory wireless EEG recorders, and ambulatory event monitors are the key factors supporting the growth of the market. According to the new market research report “Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) – Global Forecast to 2025″, published by MarketsandMarkets™, the Patient Monitoring Devices Market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Browse in-depth TOC on “Patient Monitoring Devices Market” 328 – Tables 39 – Figures 354 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678 The growth of this market is mainly driven by the growing number of hospitals across major markets, increasing awareness about vital parameter monitoring for treatment and diagnosis of chronic diseases coupled with the increasing adoption of wearable and wireless patient monitoring devices for homecare. Moreover, rising R&D investments by the key players operating in the market to develop advanced monitoring devices coupled with growing funding & grants for commercialization and development of monitoring devices are other important factors to drive the market growth in the near future. As a result of the pandemic, during March 2020 and throughout the second quarter of 2020, access to customers to sell and implement the patient monitoring devices (such as neuromonitoring devices, weight monitoring devices) diminished as hospitals became primarily focused on the COVID-19 pandemic. The pandemic has led to a significant increase in the demand for remote monitoring and patient engagement solutions. COVID-19 has led to a significant surge in demand for patient monitoring systems, and manufacturers are increasingly focusing on expanding production to meet the increasing need for respiratory monitoring devices, multi-parameter monitoring devices, blood glucose monitoring devices, cardiac monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, and fetal/neonatal monitoring devices. The ECG devices sub segment of cardiac monitoring devices products to hold major market share by 2025 Based on the product, the patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices. The cardiac monitoring devices products segment is further divided into ECG devices, event monitors, implantable loop recorders (ILRs), mobile cardiac telemetry (MCT) monitors, and smart/wearable ECG monitors. Among the cardiac monitoring devices products, the ECG devices segment held a major share of the market in 2019. The wide applications of ECG devices in CVD management are a major factor contributing to the growth of this market segment. Other factors supporting market growth include the low cost of ECG devices and the simplicity, easy-to-access nature, and compact & ergonomic design of these devices. Based on product, the blood glucose monitoring systems segment is expected to account for the largest share of the patient monitoring devices market in 2019 Based on type, the blood glucose monitoring systems market has been segmented into the self-monitoring blood glucose systems and continuous glucose monitoring system. Among these, the self-monitoring blood glucose systems sub-segment dominated the market in 2019. The major share of the segment is attributed to the rising

adoption of integrated blood glucose monitoring systems in developing as well as developed countries. New products have been introduced in the market that allow for easier result interpretation. LifeScan, for example, launched the OneTouch Verio Flex in 2016, which comes with the ColorSure technology to determine if blood glucose levels are low or high. Many manufacturers offer smartphone-connected meters that allow information transfer using Bluetooth. Request for sample pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=678 North America is expected to dominate the global patient monitoring market in 2019 North America, comprising the US and Canada, accounted for the largest share of the patient monitoring devices market in 2019. Increasing number of clinical trials validating patient monitoring devices and a growing number of approvals for patient monitoring. Are the major factors driving market growth in North America. Customers in North America are moving towards homecare patient monitoring, which requires non-invasive patient monitoring devices. This trend will have a positive impact on the market. Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (US), among othersare some of the major players operating in the global patient monitoring devices market. Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting Browse Related Reports: Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End-User (Hospital, Home Care), Indication – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of

niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/patient-healthcare-monitoring-systems-devices-market.asp Visit Our Web Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/patient-monitoring-devices.asp

[neha24blog]

Blood Glucose Monitoring Devices Market Is Estimated To Grow At A CAGR Of 7.1%Through 2026 : Grand View Research Inc.

Blood Glucose Monitoring Devices Market Is Estimated To Grow At A CAGR Of 7.1%Through 2026 : Grand View Research Inc.

San Francisco, 10 January 2020: The Report Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By End Use (Hospital, Homecare, Diagnostic Centers), By Product (Self & Continuous Monitoring), And Segment Forecasts, 2019 – 2026

The global blood glucose monitoring devices market size is expected to reach USD 17.8 billion by 2026, according to a new report by Grand View…

[techsciresearch]

Connected Sensors segment to dominate the United States Connected Drug Delivery Devices Market

Increase in awareness regarding the non-compliance of drug therapy is expected to drive the demand for United States connected drug delivery devices market for the forecast period.

According to TechSci Research report, “United States Connected Drug Delivery Devices Market By Product Type (Connected Sensors v/s Integrated Connected Devices) By Technology (Bluetooth, Near Field Communication, Others) By Application (Asthma & COPD, Diabetes, Others) By End User (Healthcare Providers v/s Homecare) By Region, Company Forecast & Opportunities, 2026”, The United States connected drug delivery devices market is expected to witness significant growth for the next five years. Connected drug delivery devices aids to maintain proper administration of drugs with ensuring no errors without the assistance of healthcare professionals. Connected drug delivery devices are quick, patient-focused, user-friendly, and easily accessible. These devices basically designed to support multifunctional tasks along with support the patient superior supervision and counselling activity. It consists of features such as reminders, adherence trackers, patient diaries which collectively store all the patient information. Increasing occurrence of chronic diseases such as diabetes, asthma and COPD is contributing to surge the demand for connected drug delivery devices. Rise in demand for connected drug delivery services by healthcare sector and home-care settings is expected to boost the connected drug delivery devices product demand. Adoption of latest technology is making connected drug delivery devices capable of drug identification and delivery.

The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected several countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Self-administration of drug delivery was promoted to provide proper treatment to patients which boosted the connected drug delivery devices demand.

Browse XX Figures spread through XX Pages and an in-depth TOC on "United States Connected Drug Delivery Devices Market”.

https://www.techsciresearch.com/report/united-states-connected-drug-delivery-devices-market/7593.html

United States connected drug delivery devices market is segmented into product type, technology, application, end user, regional distribution, and company. Based on end user, market can be divided into healthcare providers and homecare. The healthcare providers end user segment is expected to dominate the market for the forecast period, 2022-2026. Increasing prevalence of chronic diseases along with cardiovascular diseases, diabetes and chronic obstructive pulmonary diseases are some of the critical diseases requiring proper treatment and follow up of prescribed medicines. Use of connected drug delivery services is beneficial in disease treatment as it maintains the health record of patients. It also monitors the drug usage and ensure timely drug delivery; therefore, it is in high demand from healthcare sector. Based on technology, market can be fragmented into Bluetooth, near field communication, and others. The Bluetooth technology segment is expected to account for major market share for the next five years as it affordable and easily available than its other available counterparts. Bluetooth technology is in high demand as it can assist in easy connection between connected drug delivery device and smartphone. High usage and technological advancements of the technology is expected to foster the demand for connected drug delivery devices market.

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd. (USA), Teva USA, Merck & Co., West Pharmaceutical Services, Inc., Molex LLC (Phillips Medisize), Cohero Health, Inc., Becton, Dickinson, and Company, Unilife Corporation are the leading players operating in United States connected drug delivery devices market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several connected drug delivery devices manufacturers are coming up with their technologically advanced offerings.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7593

Customers can also request for 10% free customization on this report.

“High-end investments by the major players for research and development activities coupled with inclusion of emerging technologies such as big data analytics, artificial intelligence to upgrade the existing infrastructure of connected drug delivery devices is expected to carte lucrative opportunities for the market growth. Launch of novel products promoting maximum patient engagement and connectivity along with rise in geriatric population in United States who require the external assistance for drug consumption is expected to propel the connected drug delivery devices market growth till 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“United States Connected Drug Delivery Devices Market By Product Type (Connected Sensors v/s Integrated Connected Devices) By Technology (Bluetooth, Near Field Communication, Others) By Application (Asthma & COPD, Diabetes, Others) By End User (Healthcare Providers v/s Homecare) By Region, Company Forecast & Opportunities, 2026” has evaluated the future growth potential of United States connected drug delivery devices market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States connected drug delivery devices market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Web:   https://www.techsciresearch.com/